Comparison of motor response to apomorphine and levodopa in Parkinson's disease.

@article{Kempster1990ComparisonOM,
  title={Comparison of motor response to apomorphine and levodopa in Parkinson's disease.},
  author={P. A. Kempster and J. P. Frankel and Gerald M. Stern and Andrew John Lees},
  journal={Journal of Neurology, Neurosurgery \& Psychiatry},
  year={1990},
  volume={53},
  pages={1004 - 1007}
}
The magnitude and pattern of motor responses to single doses of subcutaneous apomorphine and oral levodopa were compared in 14 patients with Parkinson's disease. Although apomorphine produced much shorter motor responses than levodopa, the quality of response to the two drugs was virtually indistinguishable. These clinical observations support the notion that integrity of striatal post-synaptic dopamine receptors is a key determinant of responsiveness to dopaminergic treatment in Parkinson's… Expand
Apomorphine in the treatment of Parkinson's disease
TLDR
The historical background, structure, mechanism of action, pharmacologic properties, clinical trials, indications and side effects, as well as avenues of further research, of apomorphine are reviewed. Expand
Challenge tests to predict the dopaminergic response in untreated Parkinson's disease
TLDR
These tests have a predictive value for subsequent dopaminergic responsiveness and may help in the early differential diagnosis of parkinsonian syndromes. Expand
Apomorphine in the treatment of Parkinson's disease: a review.
TLDR
Apomorphine infusion therapy is compared with other treatments, such as oral therapy, deep brain stimulation and continuous enteral infusion of levodopa/carbidopa gel, and gives practical instructions on how to initiate treatment. Expand
Apomorphine in patients with Parkinson's disease.
TLDR
Apomorphine test appears very useful for the differential diagnosis between idiopathic Parkinson's disease and other Parkinson plus syndromes, and as a predictive test for dopaminergic responsiveness, as well as a pharmacological tool for clinical research with the aim of a better understanding of the pathophysiology of Parkinson’s disease. Expand
Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson’s disease
  • F. Grandas
  • Medicine
  • Expert review of neurotherapeutics
  • 2013
TLDR
The therapeutic effect of continuous apomorphine infusion is reviewed, practical recommendations on its use are provided and the patient's quality of life is improved. Expand
Subcutaneous Apomorphine
TLDR
These studies proved that subcutaneous apomorphine infusions are successful in aborting ‘off’ periods, reducing dyskinesias and improving Parkinson’s disease motor scores with the added benefit of a substantial levodopa-sparing effect. Expand
Somatosensory evoked potentials and dopaminergic responsiveness to apomorphine and levodopa in parkinsonian patients.
TLDR
The improvement in N30 potential occurred regardless of disease duration or the presence of motor fluctuations, suggesting SSEPs may represent an objective approach for assessing the dopaminergic response and the fluctuations of motor disability in parkinsonian patients. Expand
Low-dose clozapine improves dyskinesias in Parkinson's disease
TLDR
It is suggested that low-dose clozapine, already shown to improve psychotic symptoms, may help to reduce severe levodopa-induced dyskinesias in parkinsonian patients. Expand
The clinical use of apomorphine in Parkinson's disease
TLDR
Certain indications for its use are formulated, together with suggested approaches to modify patients' oral drug regimes so that apomorphine can best be deployed to improve their quality of life. Expand
Cardiovascular reflexes in Parkinson's disease: Effect of domperidone and apomorphine
TLDR
Apomorphine altered cardiovascular reflexes to a greater degree in patients who received the drug for the first time than in chronically treated patients, and the changes were antagonized by domperidone, a peripheral dopamine receptor antagonist. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 12 REFERENCES
Injected apomorphine and orally administered levodopa in Parkinsonism.
TLDR
The dichotomy between synergistic and antagonistic effects may be explained by the molecule of apomorphine, part of which resembles dopamine and the other resembles phenylethylamine, which can displace neurotransmitters from cellular sites. Expand
SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONS
TLDR
Results confirm that during off periods dopamine receptors remain responsive to stimulation and provide evidence of a new, effective, and well-tolerated treatment for the most disabling complication of long-term levodopa therapy. Expand
Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease.
TLDR
It is proposed that the duration of response is primarily determined by levodopa peripheral pharmacokinetics rather than by central pharmacodynamic factors associated with dopamine storage capacity. Expand
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones.
TLDR
It is proposed that systemically administered d-amphet-amine selectively depresses the firing rate of dopamine-containing cells in the substantia nigra zona compacta and adjacent ventral tegmental area of the rat midbrain and that these drugs also slow dopamine cells. Expand
Does an inhibitory action of levodopa contribute to motor fluctuations?
TLDR
The nadir of motor function in Levodopa-treated patients may not be simply loss of dopaminergic stimulation and return to the untreated state, but may represent an inhibitory effect of levodopa. Expand
The mechanisms of action of L-dopa in Parkinson's disease.
TLDR
In rodents, high doses of L-dopa significantly reduce brain serotonin levels, concomitantly increasing 5-hydroxyindoleacetic acid concentrations, and it has been proposed that L-DOPA can enter the brain serotonin neurons where it undergoes decarboxylation to dopamine (DA), which then displaces the endogenous serotonin. Expand
Apomorphine in Parkinsonian tremor.
elsewhere.) My motto for surgery in cases of perforated diverticulitis is "do as much -as necessary but as little as possible," and I regard resection of the colon as rarely necessary. The diagnosisExpand
Subcutaneous apomorphine in Parkinson's disease.
TLDR
The clinical features, diagnostic procedures and results of surgical treatment in 68 patients of Paget's disease of bone and its response to calcitonin therapy are summarized. Expand
Mechanism ofaction of exogenous L-dopa: Is it a physiological therapy for Parkinson's disease
  • Baltimore: Urban and Schwarzenberg
  • 1988
...
1
2
...